Neuropace (NPCE) logo

Neuropace (NPCE) stock

Brain implants , market cap $280M

$7.95
-2.33%

Why is NPCE down?

Down 39% from Nov 9 to Nov 20 while the S&P 500 fell 8%.

  • Neuropace fell 39% from Nov 9 to Nov 20. It fell 37% on Nov 13 alone, the session after its Nov 12 results.

Sources: Price history, Nov 20, 2026; SEC filing, Nov 12, 2026

−3Long-term trend below a falling 200-day average, down over one year, down over two years

Tell me next time NPCE moves

Free account, no card. An optional alert when NPCE moves or its score changes.Pro, $1 for a first month. An optional alert when NPCE moves or its score changes.Pro, 7 days free with a card. An optional alert when NPCE moves or its score changes.

Or see it live, free until Tuesday morning. No account.Or see one stock in full, free. No account.
1 more reason, free with an account →See every reason on NPCE →4 more reasons why NPCE fell 39% since Nov 9, from its filings, with the timeline and its peers, for Pro members.
Quality Score
-3
Poor
In its industry
#73of 86
Checks firing
0of 14
Trending down
From 52-week high
-59.4%
under its best in a year

NPCE's Quality Score fell 3 points on Fri, Nov 20, to -3. Its quiet day ended (2 chart checks stopped).

See NPCE's 14 chart checksSee NPCE's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on NPCE

Key facts on NPCE
Holding it backMoves 12.3% a day with no profit behind it
Latest filing8-K, Nov 12 Reported its quarterly results

NPCE in the news

Fri Nov 13NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance SEC filing 4:07 PM ET · Business Wire NPCE closed −37.1% that day.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

NPCE catalysts

Coming up

After its last 4 reports it closed -9.9% on average, higher 2 of 4 times.

How NPCE ranks in Medical Devices

NPCE is #73 of 86 by Quality Score.

How NPCE ranks in Medical Devices
RankStockQuality Score
73Neuropace (NPCE) logoNPCENeuropace-3

More in Medical Devices

When does NPCE report earnings, and what happens after?

Expected to report Tue Mar 2, after the close (in 101 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What NPCE reported on Nov 12, 2026

The quarter

Sales of $23.1M, 1% less than a year ago.

“The shortfall was concentrated in several of our largest accounts and reflected isolated account-level issues and changes to our field organization that created more disruption than anticipated.”

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

NPCE's results filing gives no sales by line in a table we read.

The outlook

No outlook figures read from this release.

The numbers

Market value
$280M
today
Sales
$107M
up 23% on the year
Free cash flow
-$12.4M
last 12 months

Its share count grew 10% a year over 3 years.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on NPCE: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

+0.1%-3.3%-37.1%
May 12Aug 11Nov 12
ReportedGapReaction5
days
Nov 12, 2026After close-48.0%-37.1%-32.3%
Aug 11, 2026After close-5.9%-3.3%-3.9%
May 12, 2026After close-6.1%+0.1%+0.3%

NPCE closed higher after 2 of its last 4 reports.

All 4 reports, and NPCE's Quality Score going into each

NPCE sales and profit by year

Sales and profit by year

Sales grew every year from 2020 to 2025, to $100M. It lost money in each of the six years.

Nothing is firing on NPCE right now

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on NPCE, and all 14 on every stock.Get in free →See the top 3 →Start Pro

NPCE RSI on Nov 20: 25.6, below its 50-day and 200-day averages

Not scored

RSI 25.6, MACD below signal, below both averages. Not scored.

The deep dive on NPCE

13 more findings on NPCE, each with its source, for Pro members.

NPCE insider trades

3 insiders bought $302K across 3 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyR. Scott Huennekens$104KDirectorat $8.29 on Nov 18, filed Nov 18

All 3 insider filings on NPCE from the last six months, for Pro members.

All NPCE insider trades

NPCE's officers and directors

Officers and directors with a Form 4 in the last 12 months.

See insider trades by person

Which ETFs hold NPCE?

In ETFs: NPCE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Neuropace

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

216 employeesMountain View, CAneuropace.com

What Neuropace says it competes with

“Our industry is competitive and has been evolving rapidly with the introduction of new products and technologies as well as the market activities of industry participants.”

From its annual report, SEC filing · Mar 3, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on NPCE and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn NPCE's score around: 8 things
  • 2 more filings explained, a plain line each
  • 3 more things pulling NPCE's score down
BreakawayNov 18R. Scott Huennekens bought NPCE$104K at $8.29, filed Nov 18

Alerts are optional.

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: NPCE's Quality Score is -3 (Poor), #73 of 86 in Medical Devices. Insiders bought $302K in the last 6 months (Form 4).

What does NPCE's Quality Score say?

NPCE scores -3 today, which Breakaway calls Poor. It is #73 of 86 in Medical Devices by Quality Score, with 0 of 14 chart checks firing. Down 39% from Nov 9 to Nov 20 while the S&P 500 fell 8%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is NPCE's Quality Score?

NPCE scores -3 today, which Breakaway calls Poor (below zero). That is #73 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind NPCE's -3.

Are insiders buying NPCE?

3 insiders bought $302K across 3 filings in the last 6 months. No open-⁠market sales on record. The newest is R. Scott Huennekens, Director, who bought $104K on Nov 18. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.